Corcept Therapeutics (CORT) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $122.25 +0.99%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q3 EPS of $0.11, $0.03 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $42.8 million versus the consensus estimate of $42.03 million.
GUIDANCE:
Corcept Therapeutics sees FY2017 revenue of $157-162 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Is the global equity rally broadening? UBS weighs in
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
